Showing results (401-410 of 447) with videos related to

Sort By:
Pageof 45
The Lancet. Neurology|October 15, 2023
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trialsRustam Al-Shahi Salman, Jacqueline Stephen, Jayne F Tierney, et al.
CJC Open|December 11, 2020
The Hearts in Rhythm Organization: A Canadian National Cardiogenetics NetworkBrianna Davies, Jason D Roberts, Rafik Tadros, et al.
European Journal of Human Genetics : EJHG|September 22, 2022
Identification and in-silico characterization of splice-site variants from a large cardiogenetic national registryKaveh Rayani, Brianna Davies, Matthew Cheung, et al.
European Heart Journal|March 30, 2022
Importance of genetic testing in unexplained cardiac arrestSteffany Grondin, Brianna Davies, Julia Cadrin-Tourigny, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
JACC. Heart Failure|May 3, 2019
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF TrialJonathan P Piccini, William T Abraham, Christopher Dufton, et al.
The New England Journal of Medicine|June 21, 2008
Rhythm control versus rate control for atrial fibrillation and heart failureDenis Roy, Mario Talajic, Stanley Nattel, et al.
The Canadian Journal of Cardiology|October 29, 2021
Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) ApproachDrake A Comber, Brianna Davies, Jason D Roberts, et al.
CJC Open|May 1, 2023
Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of CareMikyla L Janzen, Brianna Davies, Zachary W M Laksman, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
Pageof 45